The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Molecular markers to predict response to selective fibroblast growth factor receptor inhibitors (FGFRinh) in patients (pts) with FGFR-amplified (amp) or mutated (mut) tumors.
 
Cinta Hierro
Research Funding - Bayer (Inst)
Travel, Accommodations, Expenses - Lilly; Roche
 
Marta Serrano
No Relationships to Disclose
 
Fiorella Ruiz-Pace
No Relationships to Disclose
 
Juan Martin-Liberal
No Relationships to Disclose
 
Maria Ochoa de Olza
No Relationships to Disclose
 
Anal?A Azaro
No Relationships to Disclose
 
Irene Brana
No Relationships to Disclose
 
Maria Vieito
No Relationships to Disclose
 
Maria Alsina
No Relationships to Disclose
 
Jose Manuel Perez Garcia
No Relationships to Disclose
 
Helena Verdaguer
No Relationships to Disclose
 
Teresa Macarulla
No Relationships to Disclose
 
Monica Sanchez
No Relationships to Disclose
 
Violeta Serra
Research Funding - Bayer
 
Paolo Nuciforo
No Relationships to Disclose
 
Ana Vivancos
Consulting or Advisory Role - AstraZeneca; Merck; Sysmex
Travel, Accommodations, Expenses - Sysmex
 
Elena Garralda
No Relationships to Disclose
 
Rodrigo Dienstmann
Consulting or Advisory Role - Astellas Pharma; Roche/Genentech
Research Funding - Merck
 
Josep Tabernero
Consulting or Advisory Role - Amgen; Bayer; Boehringer Ingelheim; Celgene; Chugai Pharma; Lilly; Merck Serono; MSD; Novartis; Pfizer; Roche; Sanofi; Symphony Evolution; Taiho Pharmaceutical; Takeda
 
Jordi Rodon
Consulting or Advisory Role - Lilly; Novartis; Orion
Research Funding - Bayer (Inst); Principa Biopharma (Inst)
Travel, Accommodations, Expenses - MSD